MONOCLONAL-ANTIBODIES CAN BE USED TO CONTROL BOTH GVHD AND REJECTION IN MOUSE MODELS OF BONE-MARROW TRANSPLANTATION

MONOCLONAL-ANTIBODIES CAN BE USED TO CONTROL BOTH GVHD AND REJECTION IN MOUSE MODELS OF BONE-MARROW TRANSPLANTATION

Dades bibliogràfiques
Autors principals:	Cobbold, S, Martin, G, Waldmann, H
Format:	Journal article
Publicat:	1985

Ítems similars

Monoclonals and marrow transplants.
per: Waldmann, H, et al.
Publicat: (1986)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
per: Waldmann, H, et al.
Publicat: (1985)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
per: Waldmann, H, et al.
Publicat: (1985)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1994)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
per: Hale, G, et al.
Publicat: (1989)

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
per: Cobbold, S, et al.
Publicat: (1986)

Monoclonal antibodies for the induction of transplantation tolerance.
per: Waldmann, H, et al.
Publicat: (1993)

Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance.
per: Cobbold, S, et al.
Publicat: (1986)

HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION - INVIVO CONDITIONING WITH MONOCLONAL-ANTIBODIES
per: Fasth, A, et al.
Publicat: (1988)

RAT MONOCLONAL-ANTIBODIES TO PREVENT G-VS-H AND H-VS-G REACTIONS IN BONE-MARROW TRANSPLANTATION
per: Waldmann, H, et al.
Publicat: (1986)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
per: Hale, G, et al.
Publicat: (1996)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
per: Rebello, P, et al.
Publicat: (1999)

Separation of hemopoietic cells from adult mouse marrow by use of monoclonal antibodies.
per: Hoang, T, et al.
Publicat: (1983)

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
per: Hale, G, et al.
Publicat: (1998)

Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow.
per: Quinones, R, et al.
Publicat: (1984)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
per: Waldmann, H, et al.
Publicat: (2001)

Strain variation in susceptibility to monoclonal antibody-induced transplantation tolerance.
per: Davies, J, et al.
Publicat: (1997)

Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
per: Martin eSzyska, et al.
Publicat: (2016-03-01)

Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
per: Thierfelder, S, et al.
Publicat: (1985)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
per: Friend, P, et al.
Publicat: (1991)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1988)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
per: Hale, G, et al.
Publicat: (1983)

Therapeutic potential of monovalent monoclonal antibodies.
per: Cobbold, S, et al.
Publicat: (1984)

Availability of Campath-1 antibodies for bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1995)

The use of monoclonal antibodies to achieve immunological tolerance.
per: Waldmann, H, et al.
Publicat: (1993)

Corrigendum: Therapeutic potential of monovalent monoclonal antibodies
per: Cobbold, S, et al.
Publicat: (1984)

The use of monoclonal antibodies to achieve immunological tolerance.
per: Waldmann, H, et al.
Publicat: (1993)

Monoclonal antibodies for the therapeutic induction of tolerance.
per: Waldmann, H, et al.
Publicat: (1993)

Monoclonal antibody therapy for the induction of transplantation tolerance.
per: Cobbold, S
Publicat: (1991)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
per: Waldmann, H, et al.
Publicat: (1987)

Reprogramming the immune system for tolerance with monoclonal antibodies.
per: Cobbold, S, et al.
Publicat: (1990)

Monoclonal antibodies as agents to reinduce tolerance in autoimmunity.
per: Waldmann, H, et al.
Publicat: (1992)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
per: Hale, G, et al.
Publicat: (1985)

Segregation of mouse hemopoietic progenitor cells using the monoclonal antibody, YBM/42.
per: Watt, S, et al.
Publicat: (1983)

Advantages of rat monoclonal antibodies.
per: Clark, M, et al.
Publicat: (1983)

Immunosuppression with monoclonal antibodies--rules for effective serotherapy.
per: Cobbold, S, et al.
Publicat: (1985)

Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
per: Tighe, H, et al.
Publicat: (1988)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
per: Naparstek, E, et al.
Publicat: (1993)

Tolerance induction with CD4 monoclonal antibodies.
per: Waldmann, H, et al.
Publicat: (1998)

REDUCED INCIDENCE OF GVHD IN RECIPIENTS OF T-CELL DEPLETED MARROW
per: Apperley, J, et al.
Publicat: (1986)